Skip to content

Wetenschappelijk vervolgonderzoek Turner Oxandrolon Studie.

Transition of care in women with Turner Syndrome: Oxandrolone follow-up study.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON27906
Enrollment
130
Registered
2009-08-04
Start date
2009-08-17
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Turner syndroom (Syndroom van Turner)The main study parameters are: height, body proportions, body composition, symptoms and signs of virilization, glucose tolerance, lipid profile, cardiac conduction abnormalities, liver and thyroid function, (neuro)psychological function and quality of life.

Interventions

Participating subjects are investigated during a single, whole-day visit to the RUNMC which comprises of standardized history taking and physical examination including standardized photographs, sampli

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Completion of the original TOS protocol at least 6 months prior to the study visit; 2. Age >18 years.

Exclusion criteria

Exclusion criteria: 1. Patients who have participated in another experimental drug study within two months of entry into the present study; 2. Malignant or severely disabling disease; 3. Serious suspicion of psychiatric illnesses; 4. Pregnancy or current fertility treatment.

Design outcomes

Primary

MeasureTime frame
Final adult height.

Secondary

MeasureTime frame
1. Body proportions and composition; 2. Metabolic parameters; 3. Virilizing effects; 4. Cardiovascular, liver and thyroid function; 5. (Neuro)psychological function; 6. Quality of life.

Contacts

Public ContactHJLM Timmers

Radboud University Nijmegen Medical Centre, Department of Endocrinology 471 P.O. Box 9101

h.timmers@endo.umcn.nl+31 (0)243614599

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)